The two major intermediate filament (IF) proteins of astrocytes are vimentin and GFAP. Early during development, radial glia and immature astrocytes express mainly vimentin. Towards the end of gestation, a switch occurs whereby vimentin is progressively replaced by GFAP in differentiated astroglial cells. The expression of vimentin and GFAP increased markedly after injury to CNS. GFAP has been widely recognized as an astrocyte differentiation marker, constituting the major IF protein of mature astrocyte. In our recent researches we investigatedthe interactions between growth factors and dexamethasone on cytoskeletal proteins GFAP and vimentin expression under different experimental conditions. In addition, nestin, a currently used marker of neural stem cells, is transiently co-expressed with GFAP during development and is induced in reactive astrocytes following brain injury.The role of S100B in astrocytes, neurons, and microglia is particularly studied in Alzhèimer’s disease. In conclusion,such glial biomarkers will help us to understand the moregeneral mechanisms involved in CNS development and canopen new perspectives for the control of the neurologicdiseases.
Biomarkers of glial cell proliferation and differentiation in culture
AVOLA, Roberto
2010-01-01
Abstract
The two major intermediate filament (IF) proteins of astrocytes are vimentin and GFAP. Early during development, radial glia and immature astrocytes express mainly vimentin. Towards the end of gestation, a switch occurs whereby vimentin is progressively replaced by GFAP in differentiated astroglial cells. The expression of vimentin and GFAP increased markedly after injury to CNS. GFAP has been widely recognized as an astrocyte differentiation marker, constituting the major IF protein of mature astrocyte. In our recent researches we investigatedthe interactions between growth factors and dexamethasone on cytoskeletal proteins GFAP and vimentin expression under different experimental conditions. In addition, nestin, a currently used marker of neural stem cells, is transiently co-expressed with GFAP during development and is induced in reactive astrocytes following brain injury.The role of S100B in astrocytes, neurons, and microglia is particularly studied in Alzhèimer’s disease. In conclusion,such glial biomarkers will help us to understand the moregeneral mechanisms involved in CNS development and canopen new perspectives for the control of the neurologicdiseases.| File | Dimensione | Formato | |
|---|---|---|---|
|
Bramanti et al., Frontiers in Bioscience 2010.pdf
solo gestori archivio
Tipologia:
Versione Editoriale (PDF)
Licenza:
NON PUBBLICO - Accesso privato/ristretto
Dimensione
309.41 kB
Formato
Adobe PDF
|
309.41 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.


